Glioblasztóma: vizsgálatok itt: Olaszország
20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Aviano, Milan, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128 · EU 2025-520623-24-00 - No phaseTaking peopleRadioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)
- Where
- Milan
- Életkor
- 18 év to 80 év
- People
- 30
- Run by
- IRCCS San Raffaele
See details and how to joinNCT06551909 - No phaseTaking peoplePsychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
- Where
- Roma
- Életkor
- 18 év to 75 év
- People
- 207
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06385132 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Milan
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - No phaseTaking peopleMetabolomics and Transcriptomics of Low- and High-Grade Gliomas
- Where
- Milan
- Életkor
- 18 év and over
- People
- 220
- Run by
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
See details and how to joinNCT07832734 - 3. fázisTaking peopleLomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Where
- Bologna, Florence, Legnago, Padova, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 411 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00 - No phaseTaking peoplePET-Guided Resection in High-Grade Gliomas
- Where
- Genova, Torino
- Életkor
- 18 év and over
- People
- 100
- Run by
- Universita degli Studi di Genova
See details and how to joinNCT07567196 - 2. fázisTaking peopleOxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
- Where
- Livorno, Milan
- Életkor
- 18 év and over
- People
- 640 worldwide
- Run by
- Hopital Foch
See details and how to joinNCT04945148 · EU 2024-511026-31-01 - 2. fázisTaking peopleClinical trial on the use of metformin in addition to standard therapy in patients with high-grade glioma
- Where
- Milan
- Életkor
- 18 év and over
- People
- 25
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2024-520228-28-00 · EU 2024-520228-28-00 - 2. fázisTaking peoplePhase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
- Where
- Milan
- Életkor
- 18 év and over
- People
- 25
- Run by
- University of Milano Bicocca
See details and how to joinNCT05929495 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Ancona, Bologna, Meldola, Milan, Padova, Turin
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleGlutamate Excitotoxicity and Its Role in Glioblastoma Biology
- Where
- Milan
- Életkor
- 18 év and over
- People
- 50
- Run by
- IRCCS San Raffaele
See details and how to joinNCT05775458 - No phaseTaking peopleStem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
- Where
- Rome
- Életkor
- 18 év and over
- People
- 120
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT05941234 - No phaseNot yet taking people in OlaszországPatient's Derived Organoids for Drug Screening in Glioblastoma
- Where
- Rome
- Életkor
- 18 év and over
- People
- 100
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06781372 - No phaseTaking peopleImaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
- Where
- Rozzano
- Életkor
- 18 év and over
- People
- 75
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT06113705 - 1/2. fázisNot yet taking people in OlaszországNiraparib and Temozolomide in Patients Glioblastoma
- Where
- Rozzano
- Életkor
- 18 év and over
- People
- 86
- Run by
- Armando Santoro, MD
See details and how to joinNCT06258018 - 1/2. fázisTaking peopleA long-term monitoring study of patients suffering from a malignant neoplasm of the central nervous system previously treated with hematopoietic stem cells
- Where
- Milan
- Életkor
- 18 év and over
- People
- 5
- Run by
- Genenta Science S.p.A.
See details and how to join2024-516211-25-00 · EU 2024-516211-25-00 - 2. fázisTaking peopleVaccination with Autologous Dendritic cells loaded with Autologous Tumour homogenate in Glioblastoma: a phase II Study
- Where
- Meldola
- Életkor
- 18 év and over
- People
- 28
- Run by
- Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
See details and how to joinNCT04523688 · EU 2024-512493-98-00 - 2. fázisTaking peopleEvaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
- Where
- Florence
- Életkor
- 3 év to 30 év
- People
- 20
- Run by
- Iacopo Sardi
See details and how to joinNCT06297512 - 1/2. fázisTaking peopleSafety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
- Where
- Rome
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT04443010 · EU 2024-516357-46-00